Australian and Swiss companies enter agreement to commercialize CBD for insomnia in Australia

Australian and Swiss companies enter agreement to commercialize CBD for insomnia in Australia Australian biotech company Avecho and Swiss company Sandoz, which focuses on “off-patent’ medicines, have announced an exclusive ten-year deal for the rights to a CBD capsule for insomnia in the Australian market. The deal, announced on March 3, is a development and licensing […]